Published June 1998 | Version v1
Journal article

Technetium-99m-HMPAO- It's role in assessing peripheral perfusion

  • 1. Geelong Hospital, VIC (Australia). Department of Nuclear Medicine

Description

Full text: Excellent limb uptake of 99mTc-hexamethyl-propyleneamine oxime (99mTc-HMPAO), was observed in a patient undergoing exercise as part of the assessment for syncope. Consequent to this we employed exercise followed by injection of 99mTc-HMPAO to assess arm and finger perfusion in a patient with an AV dialysis shunt. The first patient was bicycle-exercised to a submaximal level of 75 watts before injection of 740 MBq of 99mTc-HMPAO. The study was then repeated 14 days later at rest. Relative uptake in the leg on the initial (exercise) study was 39% and on the rest study was 19% of the total body counts. The exercise study particularly outlined the active muscle groups. The second patient presented with right finger coolness and parasthesia following a brachial A-V fistula. The study showed relative finger uptake at 10 minutes post-injection of R:L 1: 1. 8, and R:L palmar uptake of 1: 1.3. The initial perfusion index for the fingers over the first 60 sec was approximately 1:10 (R:L) These two preliminary cases suggest a role for 99mTc-HMPAO in the assessment of peripheral perfusion, with uptake being influenced by both exercise and the muscle volume in the region studied

Additional details

Publishing Information

Journal Title
ANZ Nuclear Medicine
Journal Volume
29
Journal Issue
2
Journal Page Range
p. 25
ISSN
1324-1435

Conference

Title
25. Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine Inc
Dates
May 1995
Place
Brisbane, QLD (Australia)